Jason Ukman
@jasonukman.bsky.social
Editor at @statnews.bsky.social
New: Canada loses measles elimination status — as does the entire Americas region.
www.statnews.com/2025/11/10/m...
www.statnews.com/2025/11/10/m...
Canada loses measles elimination status — as does the entire Americas region
Canada has formally lost its measles elimination status, the country’s public health agency announced, triggering the loss of that status throughout all of the Americas.
www.statnews.com
November 10, 2025 at 2:49 PM
New: Canada loses measles elimination status — as does the entire Americas region.
www.statnews.com/2025/11/10/m...
www.statnews.com/2025/11/10/m...
Reposted by Jason Ukman
Does Sen. Cassidy, a strong proponent of #vaccines, regret voting to confirm RFK Jr. as health secretary? “I just have to quote Kierkegaard — You live life forward,” is his reply.
That's not a "No."
@kathmacphail.bsky.social reports. www.statnews.com/2025/11/08/b...
That's not a "No."
@kathmacphail.bsky.social reports. www.statnews.com/2025/11/08/b...
Cassidy drops into Liver Meeting to talk of shutdown, insurance overhaul and vaccines
Dropping in at the Liver Meeting, Senator Bill Cassidy argues for federally funded Flexible Spending Accounts over ACA subsidies and laments the state of vaccination.
www.statnews.com
November 9, 2025 at 5:45 PM
Does Sen. Cassidy, a strong proponent of #vaccines, regret voting to confirm RFK Jr. as health secretary? “I just have to quote Kierkegaard — You live life forward,” is his reply.
That's not a "No."
@kathmacphail.bsky.social reports. www.statnews.com/2025/11/08/b...
That's not a "No."
@kathmacphail.bsky.social reports. www.statnews.com/2025/11/08/b...
How Children’s Health Defense plans to cement its agenda beyond RFK Jr.
@danielpayne.bsky.social on the ambitions of a group that is at once at the pinnacle of its success and fiercely opposed by many in medicine.
www.statnews.com/2025/11/08/r...
@danielpayne.bsky.social on the ambitions of a group that is at once at the pinnacle of its success and fiercely opposed by many in medicine.
www.statnews.com/2025/11/08/r...
How Children’s Health Defense plans to cement its agenda beyond RFK Jr.
Children’s Health Defense is leveraging its ties to HHS to lock in legal and cultural shifts that could shape policy long after RFK Jr. leaves.
www.statnews.com
November 8, 2025 at 2:46 PM
How Children’s Health Defense plans to cement its agenda beyond RFK Jr.
@danielpayne.bsky.social on the ambitions of a group that is at once at the pinnacle of its success and fiercely opposed by many in medicine.
www.statnews.com/2025/11/08/r...
@danielpayne.bsky.social on the ambitions of a group that is at once at the pinnacle of its success and fiercely opposed by many in medicine.
www.statnews.com/2025/11/08/r...
Reposted by Jason Ukman
James Watson, the co-discoverer of the structure of DNA who died Thursday at 97, was a scientific legend and a pariah among his peers.
www.statnews.com/2025/11/07/j...
www.statnews.com/2025/11/07/j...
James Watson, dead at 97, was a scientific legend and a pariah among his peers
James Watson, the co-discoverer of the structure of DNA who died Thursday at 97, was a scientific legend and a pariah among his peers.
www.statnews.com
November 7, 2025 at 10:30 PM
James Watson, the co-discoverer of the structure of DNA who died Thursday at 97, was a scientific legend and a pariah among his peers.
www.statnews.com/2025/11/07/j...
www.statnews.com/2025/11/07/j...
Read this @statnews.com reflection on scientist James Watson — written by the great Sharon Begley before her own tragic passing. Among other things, it's a testament to her incredible talent as a writer and as an observer of this world.
www.statnews.com/2025/11/07/j...
www.statnews.com/2025/11/07/j...
James Watson, dead at 97, was a scientific legend and a pariah among his peers
James Watson, the co-discoverer of the structure of DNA who died Thursday at 97, was a scientific legend and a pariah among his peers.
www.statnews.com
November 7, 2025 at 9:06 PM
Read this @statnews.com reflection on scientist James Watson — written by the great Sharon Begley before her own tragic passing. Among other things, it's a testament to her incredible talent as a writer and as an observer of this world.
www.statnews.com/2025/11/07/j...
www.statnews.com/2025/11/07/j...
7 burning questions about Trump’s big deal for cheaper weight loss drugs.
Via @statnews.com
www.statnews.com/2025/11/06/t...
Via @statnews.com
www.statnews.com/2025/11/06/t...
7 burning questions about Trump’s big deal for cheaper weight loss drugs
Trump's weight loss drug announcement raises questions from the commercial market to Medicare.
www.statnews.com
November 7, 2025 at 12:55 AM
7 burning questions about Trump’s big deal for cheaper weight loss drugs.
Via @statnews.com
www.statnews.com/2025/11/06/t...
Via @statnews.com
www.statnews.com/2025/11/06/t...
Microdosing GLP-1 drugs? Right now, there's no robust clinical evidence doing so provides benefits.
Benefits for the companies *selling* the treatments, however, are definitely confirmed.
Via @katiepalmer.bsky.social
www.statnews.com/2025/11/04/m...
Benefits for the companies *selling* the treatments, however, are definitely confirmed.
Via @katiepalmer.bsky.social
www.statnews.com/2025/11/04/m...
Microdosing aims to extend the lifespan of the GLP-1 compounding market
Despite no strong evidence of clinical benefit, microdosing GLP-1s will likely continue as a strategy for some to profit off of the popular drug class.
www.statnews.com
November 4, 2025 at 1:42 PM
Microdosing GLP-1 drugs? Right now, there's no robust clinical evidence doing so provides benefits.
Benefits for the companies *selling* the treatments, however, are definitely confirmed.
Via @katiepalmer.bsky.social
www.statnews.com/2025/11/04/m...
Benefits for the companies *selling* the treatments, however, are definitely confirmed.
Via @katiepalmer.bsky.social
www.statnews.com/2025/11/04/m...
Reposted by Jason Ukman
5,000 steps a day could slow cognitive decline in people with signs of Alzheimer’s, a new study out in Nature Medicine suggests. My latest for @statnews.com www.statnews.com/2025/11/03/e...
5,000 steps a day could slow cognitive decline in people with signs of Alzheimer’s, study suggests
New research bolsters evidence that people with early signs of Alzheimer’s can slow cognitive decline with low to moderate physical activity.
www.statnews.com
November 3, 2025 at 5:45 PM
5,000 steps a day could slow cognitive decline in people with signs of Alzheimer’s, a new study out in Nature Medicine suggests. My latest for @statnews.com www.statnews.com/2025/11/03/e...
In Texas, the nation’s MAHA capital, many are frustrated with the status quo in health care.
A great read via @isabellacueto.bsky.social.
www.statnews.com/2025/11/03/m...
A great read via @isabellacueto.bsky.social.
www.statnews.com/2025/11/03/m...
In Texas, the nation's MAHA capital, many are frustrated with the status quo in health care
Texas is the MAHA capital of the country — offering a look at health policies that may soon roll across the country.
www.statnews.com
November 3, 2025 at 2:28 PM
In Texas, the nation’s MAHA capital, many are frustrated with the status quo in health care.
A great read via @isabellacueto.bsky.social.
www.statnews.com/2025/11/03/m...
A great read via @isabellacueto.bsky.social.
www.statnews.com/2025/11/03/m...
To summarize:
- The FDA's top drug regulator is out.
- He and the FDA's top biologics official are in open warfare.
- A lawsuit accuses him of extortion, and he accuses a former associate of the same.
Via @lizzylawrence.bsky.social @adamfeuerstein.bsky.social
www.statnews.com/2025/11/02/f...
- The FDA's top drug regulator is out.
- He and the FDA's top biologics official are in open warfare.
- A lawsuit accuses him of extortion, and he accuses a former associate of the same.
Via @lizzylawrence.bsky.social @adamfeuerstein.bsky.social
www.statnews.com/2025/11/02/f...
FDA’s top drug regulator resigns amid investigation
George Tidmarsh, the FDA's top drug regulator, has been placed on leave after being accused of abusing his regulatory authority, STAT has learned.
www.statnews.com
November 3, 2025 at 12:40 AM
To summarize:
- The FDA's top drug regulator is out.
- He and the FDA's top biologics official are in open warfare.
- A lawsuit accuses him of extortion, and he accuses a former associate of the same.
Via @lizzylawrence.bsky.social @adamfeuerstein.bsky.social
www.statnews.com/2025/11/02/f...
- The FDA's top drug regulator is out.
- He and the FDA's top biologics official are in open warfare.
- A lawsuit accuses him of extortion, and he accuses a former associate of the same.
Via @lizzylawrence.bsky.social @adamfeuerstein.bsky.social
www.statnews.com/2025/11/02/f...
The FDA's top drug regulator landed in hot water a month ago after a LinkedIn post in which he questioned the safety of a drug with ties to a former business associate.
Today, he told @lizzylawrence.bsky.social: “I was naive about the impact my words would have."
www.statnews.com/2025/11/02/f...
Today, he told @lizzylawrence.bsky.social: “I was naive about the impact my words would have."
www.statnews.com/2025/11/02/f...
FDA’s top drug regulator resigns amid investigation
George Tidmarsh, the FDA's top drug regulator, has been placed on leave after being accused of abusing his regulatory authority, STAT has learned.
www.statnews.com
November 2, 2025 at 11:48 PM
The FDA's top drug regulator landed in hot water a month ago after a LinkedIn post in which he questioned the safety of a drug with ties to a former business associate.
Today, he told @lizzylawrence.bsky.social: “I was naive about the impact my words would have."
www.statnews.com/2025/11/02/f...
Today, he told @lizzylawrence.bsky.social: “I was naive about the impact my words would have."
www.statnews.com/2025/11/02/f...
Very big news: FDA’s top drug regulator placed on leave amid investigation — as feud with Vinay Prasad becomes public.
Via @lizzylawrence.bsky.social @adamfeuerstein.bsky.social
www.statnews.com/2025/11/02/f...
Via @lizzylawrence.bsky.social @adamfeuerstein.bsky.social
www.statnews.com/2025/11/02/f...
FDA’s top drug regulator placed on leave amid investigation
George Tidmarsh, the FDA's top drug regulator, has been placed on leave after being accused of abusing his regulatory authority, STAT has learned.
www.statnews.com
November 2, 2025 at 9:51 PM
Very big news: FDA’s top drug regulator placed on leave amid investigation — as feud with Vinay Prasad becomes public.
Via @lizzylawrence.bsky.social @adamfeuerstein.bsky.social
www.statnews.com/2025/11/02/f...
Via @lizzylawrence.bsky.social @adamfeuerstein.bsky.social
www.statnews.com/2025/11/02/f...
Trump says he will help ‘Dilbert’ creator @ScottAdamsSays get cancer drug after report of access issue. Via @chelseacirruzzo.bsky.social
www.statnews.com/2025/11/02/s...
www.statnews.com/2025/11/02/s...
Trump says he will help ‘Dilbert’ creator get cancer drug
Trump posted on Truth Social that he will help Scott Adams of ‘Dilbert’ fame access Pluvicto.
www.statnews.com
November 2, 2025 at 8:18 PM
Trump says he will help ‘Dilbert’ creator @ScottAdamsSays get cancer drug after report of access issue. Via @chelseacirruzzo.bsky.social
www.statnews.com/2025/11/02/s...
www.statnews.com/2025/11/02/s...
Reposted by Jason Ukman
New from @lizzylawrence.bsky.social, based on over a dozen interviews with current and former staffers, contractors and regulatory experts.
www.statnews.com/2025/10/31/v... via @statnews.com
www.statnews.com/2025/10/31/v... via @statnews.com
Under Vinay Prasad, employees at a key FDA center fear speaking out, look for the exits
Exclusive: Vinay Prasad has rattled FDA staff by expanding his power and pushing out senior leaders.
www.statnews.com
October 31, 2025 at 1:00 PM
New from @lizzylawrence.bsky.social, based on over a dozen interviews with current and former staffers, contractors and regulatory experts.
www.statnews.com/2025/10/31/v... via @statnews.com
www.statnews.com/2025/10/31/v... via @statnews.com
Reposted by Jason Ukman
Reposted by Jason Ukman
The NIH has insisted there are no banned words
But, an analysis by @jeremymberg.bsky.social found over 700 hundred grants changed their titles from '24 to '25
Some see it as a small price to pay to keep their grant, but others are worried about what comes next
www.statnews.com/2025/10/29/n...
But, an analysis by @jeremymberg.bsky.social found over 700 hundred grants changed their titles from '24 to '25
Some see it as a small price to pay to keep their grant, but others are worried about what comes next
www.statnews.com/2025/10/29/n...
Scientists had to change more than 700 grant titles to receive NIH funding. Health disparities researchers fear what’s next
The titles of more than 700 multi-year NIH grants have been changed this year, according to an analysis by Jeremy Berg, a former agency official
www.statnews.com
October 29, 2025 at 2:00 PM
The NIH has insisted there are no banned words
But, an analysis by @jeremymberg.bsky.social found over 700 hundred grants changed their titles from '24 to '25
Some see it as a small price to pay to keep their grant, but others are worried about what comes next
www.statnews.com/2025/10/29/n...
But, an analysis by @jeremymberg.bsky.social found over 700 hundred grants changed their titles from '24 to '25
Some see it as a small price to pay to keep their grant, but others are worried about what comes next
www.statnews.com/2025/10/29/n...
New: Eli Lilly, NVIDIA announce they are teaming up to build the “most powerful supercomputer owned and operated by a pharmaceutical company.” Via @brittanytrang.com
www.statnews.com/2025/10/28/e...
www.statnews.com/2025/10/28/e...
Eli Lilly, NVIDIA team up to build pharma’s biggest AI supercomputer
Eli Lilly announced a partnership with chipmaker NVIDIA to build what it claims will be the “most powerful supercomputer owned and operated by a pharmaceutical company.”
www.statnews.com
October 28, 2025 at 6:33 PM
New: Eli Lilly, NVIDIA announce they are teaming up to build the “most powerful supercomputer owned and operated by a pharmaceutical company.” Via @brittanytrang.com
www.statnews.com/2025/10/28/e...
www.statnews.com/2025/10/28/e...
Great story: Miriam Merad’s 20-year quest to understand one cell is starting to rewrite the rules of cancer immunotherapy.
www.statnews.com/2025/10/28/m...
www.statnews.com/2025/10/28/m...
Miriam Merad’s 20-year quest to understand one cell is starting to rewrite the rules of cancer immunotherapy
Miriam Merad’s 20-year quest to understand one cell is starting to rewrite the rules of cancer immunotherapy.
www.statnews.com
October 28, 2025 at 12:38 PM
Great story: Miriam Merad’s 20-year quest to understand one cell is starting to rewrite the rules of cancer immunotherapy.
www.statnews.com/2025/10/28/m...
www.statnews.com/2025/10/28/m...
A reminder from @sarah-todd.bsky.social that politics — and policy-making — can have very real consequences for people's lives.
www.statnews.com/2025/10/27/s...
www.statnews.com/2025/10/27/s...
When SNAP benefits run out, 'people can die,' say health experts
“People can die” from even short gaps in nutrition and food access, experts say ahead of SNAP benefits not going out in November.
www.statnews.com
October 27, 2025 at 6:02 PM
A reminder from @sarah-todd.bsky.social that politics — and policy-making — can have very real consequences for people's lives.
www.statnews.com/2025/10/27/s...
www.statnews.com/2025/10/27/s...
Reposted by Jason Ukman
This looks like a win for women, but it's not so clear, and not clear why, experts told me.
www.statnews.com/2025/10/27/c...
www.statnews.com/2025/10/27/c...
For heart health, physical activity favors women
Women saw bigger drops than men in their risk of developing coronary heart disease when they followed or exceeded weekly exercise recommendations, a new study finds.
www.statnews.com
October 27, 2025 at 4:07 PM
This looks like a win for women, but it's not so clear, and not clear why, experts told me.
www.statnews.com/2025/10/27/c...
www.statnews.com/2025/10/27/c...
Insightful piece from @matthewherper.bsky.social that captures both the hopes being made possible by medical innovation and the concerns facing both drugmakers and the public.
It's also in front of the @statnews.com paywall.
It's also in front of the @statnews.com paywall.
Sometimes the biggest moments at a conference happen backstage. At the annual #STATSummit, that kind of moment involved a pharma CEO and a toddler in a tuxedo. www.statnews.com/2025/10/24/p...
At a gathering of biopharma executives, a moment of wonder — and also of worry
Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a pharma CEO and a toddler in a tuxedo.
www.statnews.com
October 24, 2025 at 5:00 PM
Insightful piece from @matthewherper.bsky.social that captures both the hopes being made possible by medical innovation and the concerns facing both drugmakers and the public.
It's also in front of the @statnews.com paywall.
It's also in front of the @statnews.com paywall.
October 24, 2025 at 3:14 PM
Reposted by Jason Ukman
How did these nine companies win priority drug review vouchers? Lizzy has the answers: www.statnews.com/2025/10/24/h...
October 24, 2025 at 2:19 PM
How did these nine companies win priority drug review vouchers? Lizzy has the answers: www.statnews.com/2025/10/24/h...
Some of the companies that received the FDA's new commissioner's priority review vouchers — fast-tracking reviews — didn't even apply for them.
Via @lizzylawrence.bsky.social
www.statnews.com/2025/10/24/h...
Via @lizzylawrence.bsky.social
www.statnews.com/2025/10/24/h...
How the first nine drug companies won priority review vouchers from Marty Makary’s FDA
The winners include a gene therapy for a rare form of deafness, a drug for vaping addiction, and a generic antibiotic.
www.statnews.com
October 24, 2025 at 1:56 PM
Some of the companies that received the FDA's new commissioner's priority review vouchers — fast-tracking reviews — didn't even apply for them.
Via @lizzylawrence.bsky.social
www.statnews.com/2025/10/24/h...
Via @lizzylawrence.bsky.social
www.statnews.com/2025/10/24/h...